Azilsartan is an angiotensin II receptor blocker with exceptionally high affinity for the AT1 receptor, providing potent and sustained blood-pressure reduction in hypertension. Simson Pharma's Azilsartan reference standard and impurities support stability-indicating method development for this ARB-class antihypertensive.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Azilsartan Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.